This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla PharmaceuticalCompany for $6.23 The post Innoviva enters agreement to acquire La Jolla PharmaceuticalCompany appeared first on Pharmaceutical Technology.
As a health policy wonk and health economist who has worked in pharmaceuticalcompanies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations.
The Janssen PharmaceuticalCompanies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).
According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceuticalcompanies. The post PDA revises report on glass container manufacturing appeared first on European Pharmaceutical Review.
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceuticalcompany will also enter into a long-term supply agreement with the CDMO.
Pharmaceuticalcompanies will undoubtedly place more emphasis on developing treatments that can be home administered and self-administered in the future, and payers and health technology assessors may well value those attributes more highly”. Pharmaceuticalcompanies cannot address this challenge alone.
The wave of interest in sustainability follows the value chain from top-tier pharmaceuticalcompanies to their suppliers of every size. About 80% of pharmaceuticalcompanies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?
Prior to this development, Innoviva signed a definitive merger agreement to acquire all of the outstanding shares of La Jolla PharmaceuticalCompany for an enterprise value of nearly $149m, through its wholly owned subsidiary.
Applying what has been learned over the last three years to update pharmaceuticalcompanies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. President, U.S. Business Unit and U.S. Country Head.
The answer to this question comes back to our definition of value. Dr Catherine Taylor is vice president, medical affairs therapy area strategy in EMEA (Europe, Middle East and Africa) at the Janssen PharmaceuticalCompanies of Johnson & Johnson. And it all fuels the debate: are medicines a cost or an investment?
Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceuticalcompany – our recent interview provided some interesting insights into the changing landscape of the industry.
No one can say definitively when the amoxicillin shortage will end. For example, some products from the pharmaceuticalcompany Sandoz are expected to be available in limited supply before the end of 2022. Bactrim (sulfamethoxazole/trimethoprim). Bactrim coupons. Augmentin (amoxicillin-clavulanate). Augmentin coupons.
Italian pharmaceuticalcompany Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in a total deal valued at up to $1.48bn. The Boards of Directors of both companies have unanimously approved the transaction. Under the deal, Amryt shareholders will receive $14.50
US-based pharmaceuticalcompanies Enliven Therapeutics and Imara have entered a definitive merger deal in an all-stock transaction to advance oncology product candidates. Once the merger has closed, a clinical-stage biopharmaceutical company will be created that will operate under the name Enliven Therapeutics.
This is definitely not because all unmet need is addressed: the WHO reports that the three leading causes of death globally, and growing, are ischaemic heart disease, stroke, and chronic obstructive pulmonary disease.
From the unknowns of blurry radiation to a world of high-definition visuals, medical imaging has pulled back the curtain on the inner workings of the human body. Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceuticalcompanies in the healthcare influencer space.
It begs the question of why only two botanical drug products have obtained FDA approval and fulfilled the Botanical Guidance definition of a botanical product. Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets.
Pharmaceuticalcompanies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. However, due to configuration differences between databases (such as code list definitions), cases may not always be an exact replica of the original case.
By the FDA definition of a biosimilar , Inflectra is highly similar to Remicade, aside from minor differences in components without clinical activity and has no clinically meaningful difference in terms of safety, purity, and potency. The pharmaceuticalcompany Janssen produces both Remicade and unbranded infliximab.
Nursing homes, dialysis centres, and long-term acute care hospitals all see considerable misuse and overuse of antimicrobials among patients who are, by definition, immunocompromised or infirm.”.
The need for therapies that can help to prolong treatment intervals for patients with wAMD is an area that pharmaceuticalcompanies continue to focus on for this indication. The latter set of therapies need to be administered on a more-frequent basis, most of them every eight weeks on average, leading to a significant treatment burden.
Now, as part of lifecycle management, pharmaceuticalcompanies are looking more closely at drugs they have on their shelves. By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs.
It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceuticalcompanies have made increasing use of biotechnology in discovering and manufacturing new medicines.
For pharmaceuticalcompanies there are a number of implications. For pharmaceuticalcompanies, this may mean a change in patient journeys to pharmacotherapy becoming longer and more complex, but also occurring in different settings. It will take a decade to fully evaluate the true impact.
Quality is a foundation for the development and delivery of pharmaceuticals: per Kopcha’s definition, quality means consistently meeting the expectations of the user. Patients expect safe and effective medicines with every dose, so pharmaceutical quality assures that every dose is safe and effective, free of contamination and defects.
Before there were pharmaceuticalcompanies, drug commercials on television, pharmacists or physicians, there were herbs and home remedies. In reality, when home remedies work, pharmaceuticalcompanies usually figure out why. Many of today’s giant pharmaceuticalcompanies got their start selling botanicals.
Content is playing an increasingly prominent role in the digital transformation of pharmaceuticalcompanies as they grapple with how to provide an engaging customer experience (CX). While many pharmaceuticalcompanies already understand the importance of CX, they do not all have the strategies they need to implement it.
Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Historically, the pharmaceutical industry has failed to meet the needs of this patient population. But where does this leave patients outside of these preferred markets?
A contrary judgment would definitely interfere too widely into trademarks’ proprietors rights, who should have the right to decide which of their products are to bear which of their trademarks. He has been advising pharmaceuticalcompanies and healthcare providers for a number of years.
There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceuticalcompanies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.
For pharmaceuticalcompanies, rare diseases present many challenges. Because when you’re a small pharma, you are betting everything on, by definition, limited resources and you’re betting everything on one drug or one mode of action, which means that if it’s fine, it’s great.
A medical affair is a pharmaceutical or medical company department that communicates the correct information about the drug or medical device to doctors, other medical practitioners and healthcare providers. Medical affairs definition uses clinical and scientific information to communicate the efficiency of a drug.
To further mitigate the growing number of challenges along the supply chain, pharmaceuticalcompanies must start to integrate healthy levels of flexibility into their processes and schedules. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.
By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.
I definitely believe that there will be a balance between the two modes, but we have now all seen that we can actually exceed expectations by being fully digital. “That’s why I have very high hopes that when the world opens up again, we will have found incredible ways of being digital – both with our employees and our stakeholders.”.
All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. 10 Diagnostics and biologics also heavily utilise carbon-based materials as constituting building blocks, processing aids, single-use reactors, or packaging materials.
PharmaceuticalcompaniesPharmaceuticalcompanies can transform their approaches to clinical trials with the help of 5G networks. 5G technology bridges the gap by connecting these patients with pharmacists or caregivers through high-definition video.
The emergence of huge pharmaceuticalcompanies with discrete centres of excellence in geographically dispersed locations has upended the classic model of one-stop shopping for all development functions. Success requires close attention to the principles of tech transfer to ensure the smoothest path to market.
If we want to lead the way in green innovation and show that the UK is open for business, we need a broader definition and recognition of innovation. We see how incentivisation has accelerated change in other sectors, such as energy, via renewable power subsidies. This is at odds with Government and NHS Net Zero ambitions and policies.
From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer. AI algorithms and machine learning models have a significant impact on the biotech industry.
Even though the technology is capable of many things, it definitely cannot prevent its users from making bad decisions and huge mistakes. Right now, numerous pharmaceuticalcompanies are investing in AI tools that don’t align with their goals, and they do that without even realizing the problem behind this investment.
We will also discuss unique specifics and critical considerations for developing a content map for pharmaceutical products. Content mapping definition is the process of planning, organizing, and delivering content that aligns with the target audience’s needs at every stage of their journey. What is Content Mapping?
00:05:44] I really have to say that outside of classroom experience is definitely missing. But I definitely do think that soft skills are lacking in your traditional pharmacy education. Question 4 [00:05:38] Well that being said, what is missing from the traditional pharmacy education? [00:05:44]
In a separate panel, Jenn Horonjeff, PhD, who is founder and CEO of Savvy Cooperative, stressed the importance of pharmaceuticalcompanies engaging with those communities in culturally-sensitive ways. The lack of an agreed lexicon and standardized definition for “decentralized clinical trial” is one such barrier.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content